News + Filings Transactions
|
Kathiresan Sekar
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 66.1k | $11.14 | $735.9k | | 05/31/2023 |
| 10/03/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 28.9k | $33.02 | $954.5k | | 10/03/2022 |
| 10/03/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 11.2k | $34.13 | $381.7k | | 10/03/2022 |
| 10/03/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 9.9k | $34.97 | $346.4k | | 10/03/2022 |
| 10/03/2022 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 50k | $1.39 | $69.5k | | 10/03/2022 |
| 08/10/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 50k | $29.90 | $1.5M | | 08/10/2022 |
| 08/10/2022 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 50k | $1.39 | $69.5k | | 08/10/2022 |
| 07/25/2022 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 71.9k | $20.46 | $1.5M | | 07/25/2022 |
| 07/19/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 50k | $29.90 | $1.5M | | 07/19/2022 |
| 07/19/2022 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 50k | $1.39 | $69.5k | | 07/19/2022 |
| 07/12/2022 | Verve Therapeutics, Inc. | | Gift | Stock Option (right to buy) | 140k | $8.24 | $1.2M | | 07/07/2022 |
| 07/12/2022 | Verve Therapeutics, Inc. | | Gift | Stock Option (right to buy) | 160k | $2.87 | $459.2k | | 07/07/2022 |
| 07/12/2022 | Verve Therapeutics, Inc. | | Gift | Stock Option (right to buy) | 140k | $8.24 | $1.2M | Sekar Kathiresan 2022 Annuity Trust | 07/07/2022 |
| 07/12/2022 | Verve Therapeutics, Inc. | | Gift | Stock Option (right to buy) | 160k | $2.87 | $459.2k | Sekar Kathiresan 2022 Annuity Trust | 07/07/2022 |
| 07/07/2022 | Verve Therapeutics, Inc. | | Gift | Common Stock | 160k | $0.00 | $0 | | 07/07/2022 |
| 07/07/2022 | Verve Therapeutics, Inc. | | Gift | Common Stock | 160k | $0.00 | $0 | Kathiresan Family 2021 Irrevocable Trust | 07/07/2022 |
| 03/18/2022 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 69.7k | $2.87 | $200k | | 03/18/2022 |
| 02/11/2022 | Verve Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 332k | $30.94 | $10.3M | | 02/11/2022 |
| 01/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 1.9k | $39.90 | $74.6k | | 01/04/2022 |
| 01/04/2022 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 1.9k | $1.39 | $2.6k | | 01/04/2022 |
| 12/28/2021 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 6.7k | $1.39 | $9.3k | | 12/27/2021 |
| 12/28/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 6.7k | $39.90 | $267.1k | | 12/27/2021 |
| 12/27/2021 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 42k | $1.39 | $58.4k | | 12/27/2021 |
| 12/27/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 36.4k | $40.02 | $1.5M | | 12/27/2021 |
| 12/27/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 4.8k | $41.24 | $197.4k | | 12/27/2021 |
| 12/27/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 770 | $42.21 | $32.5k | | 12/27/2021 |
| 12/23/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 57k | $39.90 | $2.3M | | 12/22/2021 |
| 12/23/2021 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 57k | $1.39 | $79.2k | | 12/22/2021 |
| 12/22/2021 | Verve Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 57k | $1.39 | $79.2k | | 12/22/2021 |
| 12/22/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 5.9k | $37.38 | $219.6k | | 12/22/2021 |
| 12/22/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 16.7k | $38.31 | $640.5k | | 12/22/2021 |
| 12/22/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 31.1k | $39.06 | $1.2M | | 12/22/2021 |
| 12/22/2021 | Verve Therapeutics, Inc. | | Sale | Common Stock | 3.3k | $39.78 | $130k | | 12/22/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Purchase | Common Stock | 2.5k | $19.00 | $47.5k | | 06/17/2021 |
| 06/17/2021 | Verve Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 54k | $19.00 | $1M | | 06/17/2021 |
|